Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: Construction of single and multiple mutants in a full-length cDNA cloneVirology, 1991
- TC‐83 Venezuelan equine encephalitis vaccine exposure during pregnancyTeratology, 1987
- Evaluation in Humans of a New, Inactivated Vaccine for Venezuelan Equine Encephalitis Virus (C-84)The Journal of Infectious Diseases, 1979
- Congenital cerebral and ocular malformations induced in rhesus monkeys by Venezuelan Equine Encephalitis virusTeratology, 1977
- Persistence in Humans of Antibody to Subtypes of Venezuelan Equine Encephalomyelitis (VEE) Virus after Immunization with Attenuated (TC-83) VEE Virus VaccineThe Journal of Infectious Diseases, 1977
- Inactivated Venezuelan Equine Encephalomyelitis Vaccine Prepared from Attenuated (TC-83 Strain) VirusApplied Microbiology, 1974
- Recovery of Venezuelan Equine Encephalomyelitis Virus in PanamáThe American Journal of Tropical Medicine and Hygiene, 1968
- Use of an Attenuated Strain of Venezuelan Equine Encephalo-Myelitis Virus for Immunization in ManThe American Journal of Tropical Medicine and Hygiene, 1963
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- The Causative Agent of Infectious Equine Encephalomyelitis in VenezuelaScience, 1939